Adds an additional commercial and strategic rare disease product to Eton's portfolioGalzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease DEER PARK, Ill., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback